Time-dependent enhancement of mRNA vaccines by 4-1BB costimulation
Sanchez, S.; Dangi, T.; Awakoaiye, B.; Irani, N.; Fourati, S.; Richner, J. M.; Penaloza-MacMaster, P.
Show abstract
mRNA vaccines have demonstrated efficacy against COVID-19. However, concerns regarding waning immunity and breakthrough infections have motivated the development of next-generation vaccines with enhanced efficacy. In this study, we investigated the impact of 4-1BB costimulation on immune responses elicited by mRNA vaccines in mice. We first vaccinated mice with an mRNA vaccine encoding the SARS-CoV-2 spike antigen like the Moderna and Pfizer-BioNTech vaccines, followed by administration of 4-1BB costimulatory antibodies at various times post-vaccination. Administering 4-1BB costimulatory antibodies during the priming phase did not enhance immune responses. However, administering 4-1BB costimulatory antibodies after 96 hours elicited a significant improvement in CD8 T cell responses, leading to enhanced protection against breakthrough infections. A similar improvement in immune responses was observed with multiple mRNA vaccines, including vaccines against common cold coronavirus, human immunodeficiency virus (HIV), and arenavirus. These findings demonstrate a time-dependent effect by 4-1BB costimulation and provide insights for developing improved mRNA vaccines.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Ending transmission of SARS-CoV-2: sterilizing immunity using an intranasal subunit vaccine 97%
- Omicron-specific mRNA vaccination alone and as a heterologous booster against SARS-CoV-2 97%
- A novel Mycobacterium tuberculosis-specific subunit vaccine provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin 96%
Similar papers in this journal
- Single-dose respiratory mucosal delivery of next-generation viral-vectored COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2 97%
- Humoral and cellular immune memory to four COVID-19 vaccines 97%
- Mosaic sarbecovirus nanoparticles elicit cross-reactive responses in pre-vaccinated animals 97%
Similar papers in this journal
- Bivalent mRNA booster encoding virus-like particles elicits potent polyclass RBD antibodies in pre-vaccinated mice 95%
- Early and Delayed STAT1-Dependent Responses Drive Local Trained Immunity of Macrophages in the Spleen 94%
- Preexisting memory CD4 T cells in nÏave individuals confer robust immunity upon hepatitis B vaccination 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.